nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—PPARA—prostate cancer	0.242	0.653	CbGaD
Gemfibrozil—CYP2C19—prostate cancer	0.0787	0.212	CbGaD
Gemfibrozil—CYP3A4—prostate cancer	0.05	0.135	CbGaD
Gemfibrozil—SLCO1B1—Cabazitaxel—prostate cancer	0.0316	0.0762	CbGbCtD
Gemfibrozil—SLCO1B1—Estrone—prostate cancer	0.0309	0.0745	CbGbCtD
Gemfibrozil—CYP2C8—Nilutamide—prostate cancer	0.0218	0.0526	CbGbCtD
Gemfibrozil—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0202	0.0487	CbGbCtD
Gemfibrozil—CYP2C19—Bicalutamide—prostate cancer	0.0183	0.0441	CbGbCtD
Gemfibrozil—CYP2C19—Nilutamide—prostate cancer	0.0183	0.0441	CbGbCtD
Gemfibrozil—CYP2C8—Abiraterone—prostate cancer	0.0181	0.0436	CbGbCtD
Gemfibrozil—SLCO1B1—Estradiol—prostate cancer	0.0177	0.0428	CbGbCtD
Gemfibrozil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0168	0.0406	CbGbCtD
Gemfibrozil—CYP2C9—Nilutamide—prostate cancer	0.0152	0.0367	CbGbCtD
Gemfibrozil—CYP2C9—Bicalutamide—prostate cancer	0.0152	0.0367	CbGbCtD
Gemfibrozil—CYP2C19—Flutamide—prostate cancer	0.0152	0.0366	CbGbCtD
Gemfibrozil—CYP1A2—Flutamide—prostate cancer	0.014	0.0337	CbGbCtD
Gemfibrozil—CYP2C8—Cabazitaxel—prostate cancer	0.0134	0.0322	CbGbCtD
Gemfibrozil—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0117	0.0281	CbGbCtD
Gemfibrozil—CYP1A2—Estrone—prostate cancer	0.0101	0.0244	CbGbCtD
Gemfibrozil—CYP2C9—Estrone—prostate cancer	0.00912	0.022	CbGbCtD
Gemfibrozil—CYP3A4—Bicalutamide—prostate cancer	0.00885	0.0213	CbGbCtD
Gemfibrozil—CYP3A4—Estramustine—prostate cancer	0.00823	0.0198	CbGbCtD
Gemfibrozil—CYP2C8—Estradiol—prostate cancer	0.00751	0.0181	CbGbCtD
Gemfibrozil—CYP3A4—Flutamide—prostate cancer	0.00733	0.0177	CbGbCtD
Gemfibrozil—CYP3A4—Abiraterone—prostate cancer	0.00733	0.0177	CbGbCtD
Gemfibrozil—CYP2C9—Capecitabine—prostate cancer	0.00691	0.0167	CbGbCtD
Gemfibrozil—CYP1A2—Conjugated Estrogens—prostate cancer	0.00662	0.016	CbGbCtD
Gemfibrozil—CYP2C19—Estradiol—prostate cancer	0.0063	0.0152	CbGbCtD
Gemfibrozil—CYP1A2—Estradiol—prostate cancer	0.00581	0.014	CbGbCtD
Gemfibrozil—CYP3A4—Cabazitaxel—prostate cancer	0.00542	0.0131	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—prostate cancer	0.00542	0.0131	CbGbCtD
Gemfibrozil—CYP3A4—Estrone—prostate cancer	0.0053	0.0128	CbGbCtD
Gemfibrozil—CYP2C9—Estradiol—prostate cancer	0.00524	0.0126	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—prostate cancer	0.0049	0.0118	CbGbCtD
Gemfibrozil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00473	0.0114	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—prostate cancer	0.0038	0.00915	CbGbCtD
Gemfibrozil—CYP3A4—Conjugated Estrogens—prostate cancer	0.00347	0.00836	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—prostate cancer	0.00315	0.0076	CbGbCtD
Gemfibrozil—CYP3A4—Estradiol—prostate cancer	0.00305	0.00734	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—prostate cancer	0.00262	0.00631	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—prostate cancer	0.00199	0.00479	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—prostate cancer	0.00182	0.00439	CbGbCtD
Gemfibrozil—CYP2C19—urine—prostate cancer	0.00181	0.143	CbGeAlD
Gemfibrozil—PPARA—prostate gland—prostate cancer	0.00156	0.123	CbGeAlD
Gemfibrozil—CYP1A2—urine—prostate cancer	0.00148	0.117	CbGeAlD
Gemfibrozil—CYP2C9—urine—prostate cancer	0.0014	0.111	CbGeAlD
Gemfibrozil—CYP3A4—Doxorubicin—prostate cancer	0.00136	0.00327	CbGbCtD
Gemfibrozil—PPARA—epithelium—prostate cancer	0.00115	0.0907	CbGeAlD
Gemfibrozil—CYP3A4—urine—prostate cancer	0.00107	0.0845	CbGeAlD
Gemfibrozil—PPARA—renal system—prostate cancer	0.00107	0.0842	CbGeAlD
Gemfibrozil—PPARA—testis—prostate cancer	0.000689	0.0544	CbGeAlD
Gemfibrozil—SLCO1B1—renal system—prostate cancer	0.000679	0.0537	CbGeAlD
Gemfibrozil—Bupranolol—ADRB2—prostate cancer	0.000539	1	CrCbGaD
Gemfibrozil—PPARA—lymph node—prostate cancer	0.000499	0.0394	CbGeAlD
Gemfibrozil—CYP2C8—renal system—prostate cancer	0.000386	0.0305	CbGeAlD
Gemfibrozil—CYP1A2—renal system—prostate cancer	0.000362	0.0285	CbGeAlD
Gemfibrozil—CYP3A4—renal system—prostate cancer	0.000262	0.0207	CbGeAlD
Gemfibrozil—CYP2C8—testis—prostate cancer	0.00025	0.0197	CbGeAlD
Gemfibrozil—Alopecia—Prednisone—prostate cancer	5.02e-05	0.000437	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—prostate cancer	5.01e-05	0.000436	CcSEcCtD
Gemfibrozil—Cough—Docetaxel—prostate cancer	5e-05	0.000436	CcSEcCtD
Gemfibrozil—Vertigo—Capecitabine—prostate cancer	4.99e-05	0.000434	CcSEcCtD
Gemfibrozil—Syncope—Capecitabine—prostate cancer	4.98e-05	0.000434	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—prostate cancer	4.98e-05	0.000434	CcSEcCtD
Gemfibrozil—Diarrhoea—Estradiol—prostate cancer	4.97e-05	0.000433	CcSEcCtD
Gemfibrozil—Leukopenia—Capecitabine—prostate cancer	4.97e-05	0.000433	CcSEcCtD
Gemfibrozil—Convulsion—Docetaxel—prostate cancer	4.97e-05	0.000433	CcSEcCtD
Gemfibrozil—Arthralgia—Docetaxel—prostate cancer	4.88e-05	0.000425	CcSEcCtD
Gemfibrozil—Chest pain—Docetaxel—prostate cancer	4.88e-05	0.000425	CcSEcCtD
Gemfibrozil—Myalgia—Docetaxel—prostate cancer	4.88e-05	0.000425	CcSEcCtD
Gemfibrozil—Loss of consciousness—Capecitabine—prostate cancer	4.88e-05	0.000425	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—prostate cancer	4.88e-05	0.000425	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—prostate cancer	4.87e-05	0.000424	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—prostate cancer	4.86e-05	0.000423	CcSEcCtD
Gemfibrozil—Asthenia—Mitoxantrone—prostate cancer	4.86e-05	0.000423	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—prostate cancer	4.86e-05	0.000423	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—prostate cancer	4.85e-05	0.000423	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.85e-05	0.000422	CcSEcCtD
Gemfibrozil—Cough—Capecitabine—prostate cancer	4.84e-05	0.000422	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—prostate cancer	4.82e-05	0.00042	CcSEcCtD
Gemfibrozil—Pain—Etoposide—prostate cancer	4.82e-05	0.000419	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—prostate cancer	4.82e-05	0.000419	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—prostate cancer	4.81e-05	0.000419	CcSEcCtD
Gemfibrozil—Dizziness—Estradiol—prostate cancer	4.8e-05	0.000419	CcSEcCtD
Gemfibrozil—Arthralgia—Capecitabine—prostate cancer	4.73e-05	0.000412	CcSEcCtD
Gemfibrozil—Chest pain—Capecitabine—prostate cancer	4.73e-05	0.000412	CcSEcCtD
Gemfibrozil—Myalgia—Capecitabine—prostate cancer	4.73e-05	0.000412	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—prostate cancer	4.72e-05	0.000411	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.69e-05	0.000409	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—prostate cancer	4.69e-05	0.000408	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—prostate cancer	4.68e-05	0.000408	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—prostate cancer	4.68e-05	0.000408	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—prostate cancer	4.68e-05	0.000408	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisone—prostate cancer	4.66e-05	0.000406	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—prostate cancer	4.65e-05	0.000405	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—prostate cancer	4.64e-05	0.000404	CcSEcCtD
Gemfibrozil—Diarrhoea—Mitoxantrone—prostate cancer	4.63e-05	0.000403	CcSEcCtD
Gemfibrozil—Vomiting—Estradiol—prostate cancer	4.62e-05	0.000402	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—prostate cancer	4.61e-05	0.000401	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—prostate cancer	4.6e-05	0.000401	CcSEcCtD
Gemfibrozil—Nervous system disorder—Docetaxel—prostate cancer	4.59e-05	0.0004	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—prostate cancer	4.58e-05	0.000399	CcSEcCtD
Gemfibrozil—Rash—Estradiol—prostate cancer	4.58e-05	0.000399	CcSEcCtD
Gemfibrozil—Dermatitis—Estradiol—prostate cancer	4.58e-05	0.000399	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—prostate cancer	4.57e-05	0.000398	CcSEcCtD
Gemfibrozil—Confusional state—Capecitabine—prostate cancer	4.57e-05	0.000398	CcSEcCtD
Gemfibrozil—Headache—Estradiol—prostate cancer	4.55e-05	0.000396	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—prostate cancer	4.55e-05	0.000396	CcSEcCtD
Gemfibrozil—Oedema—Capecitabine—prostate cancer	4.53e-05	0.000395	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—prostate cancer	4.52e-05	0.000394	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—prostate cancer	4.5e-05	0.000392	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—prostate cancer	4.49e-05	0.000391	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—prostate cancer	4.47e-05	0.00039	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—prostate cancer	4.46e-05	0.000389	CcSEcCtD
Gemfibrozil—Shock—Capecitabine—prostate cancer	4.46e-05	0.000388	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—prostate cancer	4.45e-05	0.000388	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—prostate cancer	4.45e-05	0.000388	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—prostate cancer	4.45e-05	0.000388	CcSEcCtD
Gemfibrozil—Nervous system disorder—Capecitabine—prostate cancer	4.44e-05	0.000387	CcSEcCtD
Gemfibrozil—Vertigo—Prednisone—prostate cancer	4.44e-05	0.000387	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Capecitabine—prostate cancer	4.44e-05	0.000386	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—prostate cancer	4.44e-05	0.000386	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—prostate cancer	4.42e-05	0.000385	CcSEcCtD
Gemfibrozil—Skin disorder—Capecitabine—prostate cancer	4.4e-05	0.000383	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—prostate cancer	4.37e-05	0.00038	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—prostate cancer	4.35e-05	0.000379	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—prostate cancer	4.33e-05	0.000377	CcSEcCtD
Gemfibrozil—Nausea—Estradiol—prostate cancer	4.32e-05	0.000376	CcSEcCtD
Gemfibrozil—Vomiting—Mitoxantrone—prostate cancer	4.3e-05	0.000375	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—prostate cancer	4.28e-05	0.000373	CcSEcCtD
Gemfibrozil—Rash—Mitoxantrone—prostate cancer	4.27e-05	0.000372	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—prostate cancer	4.26e-05	0.000371	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.26e-05	0.000371	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—prostate cancer	4.24e-05	0.000369	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—prostate cancer	4.21e-05	0.000367	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—prostate cancer	4.21e-05	0.000367	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—prostate cancer	4.2e-05	0.000366	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.18e-05	0.000364	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—prostate cancer	4.16e-05	0.000362	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—prostate cancer	4.15e-05	0.000362	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.13e-05	0.00036	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—prostate cancer	4.12e-05	0.000359	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—prostate cancer	4.12e-05	0.000359	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—prostate cancer	4.09e-05	0.000356	CcSEcCtD
Gemfibrozil—Paraesthesia—Capecitabine—prostate cancer	4.07e-05	0.000354	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—prostate cancer	4.04e-05	0.000352	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—prostate cancer	4.04e-05	0.000352	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—prostate cancer	4.04e-05	0.000352	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—prostate cancer	4.04e-05	0.000352	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—prostate cancer	4.04e-05	0.000352	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—prostate cancer	4.04e-05	0.000351	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—prostate cancer	4.02e-05	0.00035	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—prostate cancer	4e-05	0.000349	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—prostate cancer	4e-05	0.000349	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—prostate cancer	4e-05	0.000349	CcSEcCtD
Gemfibrozil—Dyspepsia—Capecitabine—prostate cancer	3.99e-05	0.000347	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—prostate cancer	3.98e-05	0.000347	CcSEcCtD
Gemfibrozil—Shock—Prednisone—prostate cancer	3.97e-05	0.000346	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—prostate cancer	3.96e-05	0.000345	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—prostate cancer	3.93e-05	0.000342	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—prostate cancer	3.92e-05	0.000341	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Capecitabine—prostate cancer	3.91e-05	0.000341	CcSEcCtD
Gemfibrozil—Fatigue—Capecitabine—prostate cancer	3.91e-05	0.00034	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—prostate cancer	3.89e-05	0.000339	CcSEcCtD
Gemfibrozil—Constipation—Capecitabine—prostate cancer	3.87e-05	0.000337	CcSEcCtD
Gemfibrozil—Pain—Capecitabine—prostate cancer	3.87e-05	0.000337	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—prostate cancer	3.86e-05	0.000336	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—prostate cancer	3.85e-05	0.000336	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—prostate cancer	3.84e-05	0.000335	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—prostate cancer	3.83e-05	0.000333	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—prostate cancer	3.81e-05	0.000332	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—prostate cancer	3.8e-05	0.000331	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—prostate cancer	3.79e-05	0.00033	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—prostate cancer	3.76e-05	0.000327	CcSEcCtD
Gemfibrozil—Feeling abnormal—Capecitabine—prostate cancer	3.73e-05	0.000325	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—prostate cancer	3.72e-05	0.000324	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Capecitabine—prostate cancer	3.71e-05	0.000323	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—prostate cancer	3.71e-05	0.000323	CcSEcCtD
Gemfibrozil—Abdominal pain—Docetaxel—prostate cancer	3.7e-05	0.000322	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—prostate cancer	3.68e-05	0.00032	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—prostate cancer	3.65e-05	0.000317	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—prostate cancer	3.63e-05	0.000316	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—prostate cancer	3.62e-05	0.000316	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—prostate cancer	3.6e-05	0.000314	CcSEcCtD
Gemfibrozil—Urticaria—Capecitabine—prostate cancer	3.6e-05	0.000314	CcSEcCtD
Gemfibrozil—Abdominal pain—Capecitabine—prostate cancer	3.58e-05	0.000312	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—prostate cancer	3.58e-05	0.000312	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—prostate cancer	3.58e-05	0.000311	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Gemfibrozil—Rash—Etoposide—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Gemfibrozil—Headache—Etoposide—prostate cancer	3.53e-05	0.000307	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—prostate cancer	3.53e-05	0.000307	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—prostate cancer	3.51e-05	0.000306	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—prostate cancer	3.5e-05	0.000305	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—prostate cancer	3.48e-05	0.000303	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—prostate cancer	3.48e-05	0.000303	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—prostate cancer	3.48e-05	0.000303	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—prostate cancer	3.47e-05	0.000302	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—prostate cancer	3.46e-05	0.000302	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—prostate cancer	3.45e-05	0.000301	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—prostate cancer	3.4e-05	0.000296	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—prostate cancer	3.38e-05	0.000294	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—prostate cancer	3.37e-05	0.000294	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—prostate cancer	3.36e-05	0.000292	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—prostate cancer	3.35e-05	0.000292	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—prostate cancer	3.35e-05	0.000291	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—prostate cancer	3.33e-05	0.00029	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—prostate cancer	3.31e-05	0.000288	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—prostate cancer	3.31e-05	0.000288	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—prostate cancer	3.3e-05	0.000287	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—prostate cancer	3.29e-05	0.000287	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—prostate cancer	3.29e-05	0.000287	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—prostate cancer	3.29e-05	0.000287	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.27e-05	0.000285	CcSEcCtD
Gemfibrozil—Asthenia—Capecitabine—prostate cancer	3.25e-05	0.000283	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—prostate cancer	3.22e-05	0.00028	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—prostate cancer	3.21e-05	0.00028	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—prostate cancer	3.21e-05	0.000279	CcSEcCtD
Gemfibrozil—Pruritus—Capecitabine—prostate cancer	3.21e-05	0.000279	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—prostate cancer	3.2e-05	0.000279	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—prostate cancer	3.2e-05	0.000279	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—prostate cancer	3.19e-05	0.000278	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—prostate cancer	3.18e-05	0.000277	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—prostate cancer	3.16e-05	0.000275	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—prostate cancer	3.16e-05	0.000275	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—prostate cancer	3.12e-05	0.000272	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—prostate cancer	3.11e-05	0.000271	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—prostate cancer	3.1e-05	0.00027	CcSEcCtD
Gemfibrozil—Diarrhoea—Capecitabine—prostate cancer	3.1e-05	0.00027	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—prostate cancer	3.1e-05	0.00027	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—prostate cancer	3.09e-05	0.00027	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—prostate cancer	3.09e-05	0.000269	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—prostate cancer	3.07e-05	0.000267	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.03e-05	0.000264	CcSEcCtD
Gemfibrozil—Dizziness—Capecitabine—prostate cancer	3e-05	0.000261	CcSEcCtD
Gemfibrozil—Vomiting—Docetaxel—prostate cancer	2.98e-05	0.000259	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—prostate cancer	2.95e-05	0.000257	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—prostate cancer	2.95e-05	0.000257	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—prostate cancer	2.95e-05	0.000257	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—prostate cancer	2.93e-05	0.000255	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—prostate cancer	2.92e-05	0.000254	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—prostate cancer	2.92e-05	0.000254	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—prostate cancer	2.9e-05	0.000252	CcSEcCtD
Gemfibrozil—Vomiting—Capecitabine—prostate cancer	2.88e-05	0.000251	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.88e-05	0.000251	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—prostate cancer	2.87e-05	0.00025	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—prostate cancer	2.86e-05	0.000249	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—prostate cancer	2.86e-05	0.000249	CcSEcCtD
Gemfibrozil—Rash—Capecitabine—prostate cancer	2.86e-05	0.000249	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—prostate cancer	2.86e-05	0.000249	CcSEcCtD
Gemfibrozil—Dermatitis—Capecitabine—prostate cancer	2.85e-05	0.000249	CcSEcCtD
Gemfibrozil—Headache—Capecitabine—prostate cancer	2.84e-05	0.000247	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—prostate cancer	2.84e-05	0.000247	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—prostate cancer	2.83e-05	0.000247	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—prostate cancer	2.81e-05	0.000244	CcSEcCtD
Gemfibrozil—Nausea—Docetaxel—prostate cancer	2.78e-05	0.000242	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—prostate cancer	2.78e-05	0.000242	CcSEcCtD
Gemfibrozil—Diarrhoea—Prednisone—prostate cancer	2.76e-05	0.000241	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—prostate cancer	2.73e-05	0.000237	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—prostate cancer	2.72e-05	0.000237	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—prostate cancer	2.7e-05	0.000235	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—prostate cancer	2.7e-05	0.000235	CcSEcCtD
Gemfibrozil—Nausea—Capecitabine—prostate cancer	2.69e-05	0.000234	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—prostate cancer	2.67e-05	0.000232	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.66e-05	0.000232	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—prostate cancer	2.62e-05	0.000228	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—prostate cancer	2.6e-05	0.000227	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—prostate cancer	2.6e-05	0.000226	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—prostate cancer	2.58e-05	0.000225	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—prostate cancer	2.57e-05	0.000224	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—prostate cancer	2.57e-05	0.000224	CcSEcCtD
Gemfibrozil—Rash—Prednisone—prostate cancer	2.54e-05	0.000222	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—prostate cancer	2.54e-05	0.000221	CcSEcCtD
Gemfibrozil—Headache—Prednisone—prostate cancer	2.53e-05	0.00022	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.52e-05	0.00022	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—prostate cancer	2.52e-05	0.000219	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—prostate cancer	2.51e-05	0.000218	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—prostate cancer	2.5e-05	0.000218	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—prostate cancer	2.5e-05	0.000218	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—prostate cancer	2.5e-05	0.000217	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—prostate cancer	2.41e-05	0.00021	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—prostate cancer	2.4e-05	0.000209	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—prostate cancer	2.39e-05	0.000208	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—prostate cancer	2.32e-05	0.000202	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—prostate cancer	2.31e-05	0.000201	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—prostate cancer	2.26e-05	0.000197	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—prostate cancer	2.23e-05	0.000195	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—prostate cancer	2.16e-05	0.000188	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—prostate cancer	2.1e-05	0.000183	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—prostate cancer	2.09e-05	0.000182	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—prostate cancer	2.07e-05	0.00018	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—prostate cancer	2.01e-05	0.000175	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—prostate cancer	2e-05	0.000174	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—prostate cancer	1.99e-05	0.000173	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—prostate cancer	1.99e-05	0.000173	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—prostate cancer	1.98e-05	0.000172	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—prostate cancer	1.93e-05	0.000168	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—prostate cancer	1.88e-05	0.000163	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—prostate cancer	1.86e-05	0.000162	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—prostate cancer	1.84e-05	0.00016	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—prostate cancer	1.84e-05	0.00016	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—prostate cancer	1.83e-05	0.000159	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—prostate cancer	1.73e-05	0.000151	CcSEcCtD
Gemfibrozil—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.08e-06	3.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TH—prostate cancer	3.07e-06	3.56e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UCP3—prostate cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PDHA1—prostate cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TCN2—prostate cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA3—prostate cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ACHE—prostate cancer	3.05e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—prostate cancer	3.05e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.05e-06	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.04e-06	3.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.04e-06	3.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.03e-06	3.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOA2—prostate cancer	3.02e-06	3.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.02e-06	3.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.01e-06	3.48e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SULT2A1—prostate cancer	3e-06	3.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—prostate cancer	2.99e-06	3.46e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MED12—prostate cancer	2.95e-06	3.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKR1C3—prostate cancer	2.94e-06	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GNG5—prostate cancer	2.93e-06	3.39e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—INS—prostate cancer	2.92e-06	3.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PRKACB—prostate cancer	2.92e-06	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.91e-06	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.91e-06	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GGT1—prostate cancer	2.9e-06	3.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.89e-06	3.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—prostate cancer	2.88e-06	3.34e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CREBBP—prostate cancer	2.86e-06	3.32e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOA1—prostate cancer	2.85e-06	3.3e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.85e-06	3.3e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA3—prostate cancer	2.82e-06	3.27e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP2E1—prostate cancer	2.82e-06	3.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP19A1—prostate cancer	2.81e-06	3.26e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA4—prostate cancer	2.79e-06	3.24e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.79e-06	3.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NQO1—prostate cancer	2.78e-06	3.22e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.77e-06	3.21e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOA2—prostate cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TH—prostate cancer	2.74e-06	3.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.73e-06	3.16e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA2—prostate cancer	2.72e-06	3.15e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—prostate cancer	2.72e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.71e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RXRA—prostate cancer	2.71e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.7e-06	3.13e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPGDS—prostate cancer	2.69e-06	3.12e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG5—prostate cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—prostate cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.67e-06	3.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.67e-06	3.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.64e-06	3.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.63e-06	3.04e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA1—prostate cancer	2.63e-06	3.04e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—COMT—prostate cancer	2.61e-06	3.03e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—prostate cancer	2.61e-06	3.02e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACHE—prostate cancer	2.61e-06	3.02e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—prostate cancer	2.6e-06	3.01e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.6e-06	3.01e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTO1—prostate cancer	2.6e-06	3.01e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT2—prostate cancer	2.6e-06	3.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GGT1—prostate cancer	2.58e-06	2.99e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.58e-06	2.99e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.57e-06	2.98e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.57e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—prostate cancer	2.56e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ITPR1—prostate cancer	2.56e-06	2.96e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—prostate cancer	2.56e-06	2.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOA1—prostate cancer	2.55e-06	2.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NQO1—prostate cancer	2.54e-06	2.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.51e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.51e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TH—prostate cancer	2.5e-06	2.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PRKACB—prostate cancer	2.5e-06	2.89e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LRP2—prostate cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLCB2—prostate cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.48e-06	2.87e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.47e-06	2.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.46e-06	2.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—P4HB—prostate cancer	2.44e-06	2.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.43e-06	2.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RXRA—prostate cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMS—prostate cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—prostate cancer	2.39e-06	2.77e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.38e-06	2.75e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.37e-06	2.74e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GGT1—prostate cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA2—prostate cancer	2.35e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LPL—prostate cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—COMT—prostate cancer	2.33e-06	2.7e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—prostate cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOA1—prostate cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.32e-06	2.68e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.29e-06	2.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ITPR1—prostate cancer	2.28e-06	2.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MED12—prostate cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.27e-06	2.62e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GNG5—prostate cancer	2.26e-06	2.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ERCC2—prostate cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RXRA—prostate cancer	2.21e-06	2.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.19e-06	2.54e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA3—prostate cancer	2.18e-06	2.52e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NQO1—prostate cancer	2.17e-06	2.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMS—prostate cancer	2.16e-06	2.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TH—prostate cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—prostate cancer	2.13e-06	2.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—COMT—prostate cancer	2.13e-06	2.46e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.12e-06	2.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—prostate cancer	2.12e-06	2.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.12e-06	2.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—prostate cancer	2.11e-06	2.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.1e-06	2.44e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LPL—prostate cancer	2.09e-06	2.43e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—prostate cancer	2.09e-06	2.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ITPR1—prostate cancer	2.08e-06	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.08e-06	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPGDS—prostate cancer	2.08e-06	2.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARA—prostate cancer	2.07e-06	2.4e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.06e-06	2.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—prostate cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.02e-06	2.34e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—prostate cancer	2.01e-06	2.33e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACHE—prostate cancer	2.01e-06	2.33e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GGT1—prostate cancer	2.01e-06	2.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ERCC2—prostate cancer	2.01e-06	2.32e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.99e-06	2.31e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA1—prostate cancer	1.98e-06	2.3e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMS—prostate cancer	1.97e-06	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.96e-06	2.26e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—prostate cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAV1—prostate cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—prostate cancer	1.95e-06	2.25e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.94e-06	2.24e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PRKACB—prostate cancer	1.93e-06	2.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LPL—prostate cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RXRA—prostate cancer	1.89e-06	2.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—prostate cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.86e-06	2.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARA—prostate cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.84e-06	2.14e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.84e-06	2.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ERCC2—prostate cancer	1.83e-06	2.12e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—COMT—prostate cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA2—prostate cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—prostate cancer	1.81e-06	2.09e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ITPR1—prostate cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.75e-06	2.03e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAV1—prostate cancer	1.74e-06	2.01e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.73e-06	2.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—prostate cancer	1.72e-06	1.99e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.69e-06	1.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARA—prostate cancer	1.69e-06	1.95e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMS—prostate cancer	1.68e-06	1.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—INS—prostate cancer	1.68e-06	1.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NQO1—prostate cancer	1.67e-06	1.94e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—prostate cancer	1.66e-06	1.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TH—prostate cancer	1.65e-06	1.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CREBBP—prostate cancer	1.65e-06	1.91e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LPL—prostate cancer	1.63e-06	1.89e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.6e-06	1.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAV1—prostate cancer	1.59e-06	1.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.58e-06	1.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.58e-06	1.82e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ERCC2—prostate cancer	1.56e-06	1.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.56e-06	1.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GGT1—prostate cancer	1.55e-06	1.8e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA1—prostate cancer	1.53e-06	1.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.52e-06	1.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.51e-06	1.75e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—INS—prostate cancer	1.5e-06	1.74e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—prostate cancer	1.47e-06	1.71e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—prostate cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CREBBP—prostate cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RXRA—prostate cancer	1.46e-06	1.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.44e-06	1.67e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.44e-06	1.67e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARA—prostate cancer	1.44e-06	1.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—COMT—prostate cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—prostate cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ITPR1—prostate cancer	1.37e-06	1.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—INS—prostate cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAV1—prostate cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—prostate cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CREBBP—prostate cancer	1.34e-06	1.55e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—prostate cancer	1.32e-06	1.52e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMS—prostate cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.29e-06	1.5e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—prostate cancer	1.28e-06	1.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LPL—prostate cancer	1.26e-06	1.46e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.23e-06	1.43e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.22e-06	1.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.41e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ERCC2—prostate cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—prostate cancer	1.2e-06	1.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—prostate cancer	1.2e-06	1.39e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—prostate cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—prostate cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—INS—prostate cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CREBBP—prostate cancer	1.14e-06	1.33e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—prostate cancer	1.13e-06	1.31e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—prostate cancer	1.12e-06	1.3e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARA—prostate cancer	1.11e-06	1.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—prostate cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.09e-06	1.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—prostate cancer	1.05e-06	1.21e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAV1—prostate cancer	1.05e-06	1.21e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—prostate cancer	1.02e-06	1.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—prostate cancer	1e-06	1.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—prostate cancer	9.57e-07	1.11e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.53e-07	1.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—prostate cancer	9.46e-07	1.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—prostate cancer	9.37e-07	1.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—prostate cancer	9.12e-07	1.06e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—INS—prostate cancer	9.02e-07	1.04e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CREBBP—prostate cancer	8.83e-07	1.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.38e-07	9.7e-06	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.29e-07	9.6e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—prostate cancer	8.17e-07	9.46e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—prostate cancer	7.91e-07	9.16e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—prostate cancer	7.8e-07	9.03e-06	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.4e-07	8.57e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.3e-07	8.45e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—prostate cancer	7.23e-07	8.38e-06	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—prostate cancer	6.77e-07	7.84e-06	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.75e-07	7.81e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—prostate cancer	6.31e-07	7.3e-06	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—prostate cancer	6.05e-07	7e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—prostate cancer	6.02e-07	6.97e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.77e-07	6.68e-06	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—prostate cancer	5.51e-07	6.38e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—prostate cancer	4.71e-07	5.45e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.45e-07	5.15e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—prostate cancer	3.64e-07	4.21e-06	CbGpPWpGaD
